James C. Foster - 06 Jun 2022 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Chairman, President and CEO, Director
Signature
/s/ James C. Foster
Issuer symbol
CRL
Transactions as of
06 Jun 2022
Net transactions value
$0
Form type
4
Filing time
31 Jan 2023, 16:57:02 UTC
Previous filing
01 Jun 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Gift $0 -2,000 -0.94% $0.000000 211,711 06 Jun 2022 Direct F1, F2
transaction CRL Common Stock Award $0 +49,725 +24% $0.000000 254,375 27 Jan 2023 Direct F1, F2, F3
transaction CRL Common Stock Tax liability $0 -21,453 -8.4% $0.000000 232,922 27 Jan 2023 Direct F1, F2
holding CRL Common Stock 11,000 06 Jun 2022 2022 GRAT F2
holding CRL Common Stock 8,000 06 Jun 2022 2021 GRAT
holding CRL Common Stock 13,640 06 Jun 2022 2020 GRAT F1
holding CRL Common Stock 750 06 Jun 2022 By Trust
holding CRL Common Stock 340 06 Jun 2022 By Trust
holding CRL Common Stock 2,250 06 Jun 2022 By Trust
holding CRL Common Stock 10,000 06 Jun 2022 Held By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On 06/07/2022: 3,939 shares were transferred from the 2020 GRAT account to Direct Holdings.
F2 On 10/11/2022, the reporting person contributed 11,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his adult children.
F3 Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 29, 2020.